High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

May 31, 1996

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL

filgrastim

DRUG

melphalan

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

Fox Chase-Temple Cancer Center CCOP Research Base, Philadelphia

All Listed Sponsors

lead

Temple University

OTHER

NCT00002810 - High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis | Biotech Hunter | Biotech Hunter